174 related articles for article (PubMed ID: 35159367)
1. Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose Intolerance.
Gupte M; Tousif S; Lemon JJ; Toro Cora A; Umbarkar P; Lal H
Cells; 2022 Feb; 11(3):. PubMed ID: 35159367
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity.
Gupte M; Umbarkar P; Singh AP; Zhang Q; Tousif S; Lal H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365965
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
Gupte M; Tumuluru S; Sui JY; Singh AP; Umbarkar P; Parikh SS; Ahmad F; Zhang Q; Force T; Lal H
Int J Cardiol; 2018 May; 259():145-152. PubMed ID: 29398139
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
5. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model.
Trajcevski KE; O'Neill HM; Wang DC; Thomas MM; Al-Sajee D; Steinberg GR; Ceddia RB; Hawke TJ
PLoS One; 2013; 8(8):e71747. PubMed ID: 23951235
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.
MacAulay K; Doble BW; Patel S; Hansotia T; Sinclair EM; Drucker DJ; Nagy A; Woodgett JR
Cell Metab; 2007 Oct; 6(4):329-37. PubMed ID: 17908561
[TBL] [Abstract][Full Text] [Related]
7. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
8. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
[TBL] [Abstract][Full Text] [Related]
9. Prolyl hydroxylase domain protein 2 plays a critical role in diet-induced obesity and glucose intolerance.
Matsuura H; Ichiki T; Inoue E; Nomura M; Miyazaki R; Hashimoto T; Ikeda J; Takayanagi R; Fong GH; Sunagawa K
Circulation; 2013 May; 127(21):2078-87. PubMed ID: 23630130
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
11. Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3β.
Wohua Z; Weiming X
Biomed Pharmacother; 2019 Oct; 118():108940. PubMed ID: 31382130
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific analysis of glycogen synthase kinase-3α (GSK-3α) in glucose metabolism: effect of strain variation.
Patel S; Macaulay K; Woodgett JR
PLoS One; 2011 Jan; 6(1):e15845. PubMed ID: 21253590
[TBL] [Abstract][Full Text] [Related]
13. Switching from high-fat feeding (HFD) to regular diet improves metabolic and behavioral impairments in middle-aged female mice.
Braga SP; Delanogare E; Machado AE; Prediger RD; Moreira ELG
Behav Brain Res; 2021 Feb; 398():112969. PubMed ID: 33075395
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
Sampath C; Srinivasan S; Freeman ML; Gangula PR
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G481-G493. PubMed ID: 32812777
[TBL] [Abstract][Full Text] [Related]
15. Deletion of interleukin 1 receptor-associated kinase 1 (
Sun XJ; Kim SP; Zhang D; Sun H; Cao Q; Lu X; Ying Z; Li L; Henry RR; Ciaraldi TP; Taylor SI; Quon MJ
J Biol Chem; 2017 Jul; 292(29):12339-12350. PubMed ID: 28572512
[TBL] [Abstract][Full Text] [Related]
16. Active Glycogen Synthase in the Liver Prevents High-Fat Diet-Induced Glucose Intolerance, Decreases Food Intake, and Lowers Body Weight.
López-Soldado I; Guinovart JJ; Duran J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768897
[TBL] [Abstract][Full Text] [Related]
17. Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice.
Pfuhlmann K; Pfluger PT; Schriever SC; Müller TD; Tschöp MH; Stemmer K
PLoS One; 2017; 12(9):e0183488. PubMed ID: 28873424
[TBL] [Abstract][Full Text] [Related]
18. High-fat diet-induced impairment of skeletal muscle insulin sensitivity is not prevented by SIRT1 overexpression.
White AT; Philp A; Fridolfsson HN; Schilling JM; Murphy AN; Hamilton DL; McCurdy CE; Patel HH; Schenk S
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E764-72. PubMed ID: 25159328
[TBL] [Abstract][Full Text] [Related]
19. AHNAK KO mice are protected from diet-induced obesity but are glucose intolerant.
Ramdas M; Harel C; Armoni M; Karnieli E
Horm Metab Res; 2015 Apr; 47(4):265-72. PubMed ID: 25153686
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice.
Coyne ES; Bédard N; Gong YJ; Faraj M; Tchernof A; Wing SS
Diabetologia; 2019 Jan; 62(1):136-146. PubMed ID: 30386869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
